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T2* Mapping of Articular Cartilage
Current Status of Research and First Clinical Applications
Gustav Andreisek, MD, MBA* and Markus Weiger, PhDÞ
Abstract: T2* mapping is a relatively new method for the compositional as-
sessment of the articular cartilage. Typically, a multigradient echo or an ul-
trashort echo time imaging technique with a range of short and very short echo
times is used. In most studies, imaging is performed at a high field strength,
that is, 3 and 7 T. Postprocessing includes exponential fitting of relaxation
decay and manual region-of-interestYbased measurements of T2* times on
T2* maps. Detailed analyses of T2* times of articular cartilage have shown
distinct T2* components with shorter and longer T2* times. Moreover, there is
a zonal distribution with a significant depthwise gradient of T2*, with rela-
tively short times near the osteochondral junction and relatively long times at
the cartilage’s surface. T2* times of normal articular cartilage at the knee are,
when averaged over the whole cartilage thickness and using monoexponential
fitting, approximately 20 milliseconds. The results of recent studies have
shown a good test-retest as well as interreader and intrareader reliabilities for
T2* mapping. This article provides a descriptive review of the current litera-
ture, briefly discusses the technique itself, and provides an outlook on future
research questions and possible clinical applications.
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BACKGROUND
The articular cartilage is a highly specialized tissue and has a com-
plex ultrastructure. It mainly consists of water (approximately 75%),
collagen and proteoglycans (approximately 24%), and cellular ma-
terial, that is, chondrocytes (approximately 1%). It typically shows a
zonal microanatomy with collagen fibers oriented perpendicular to
the surface in the deep layers and parallel to the surface at the very
superficial layer. The articular cartilage has unique biomechanical
properties because it distributes the load to the bone while providing
a low-friction, weight-bearing surface. Overall, the articular cartilage
is essential for the biomechanical function of joints.1Y3
Articular cartilage can acutely be damaged during trauma and
chronically by degenerative changes. The common pathway for both
types of damage is the development of osteoarthritis. In very early
osteoarthritis, there is often no obvious morphological change to the
cartilage tissue. Usually, the articular cartilage is intact without su-
perficial fissures, often one of the first morphological signs of car-
tilage degradation. Advancing osteoarthritis, at some point, leads to
morphological changes, which include further fissuring, clefts, and
loss of substance. The goal of modern quantitative imaging tech-
niques is to detect such very early changes in the articular cartilage.
Detection of changes within the articular cartilage at the absence of
early morphological changes on standard imaging would be favorable
in terms of preventive approaches and potential cartilage-preserving
therapies.
With the event of new therapeutic options such as dietary sup-
plementation, intra-articular injection of hyaluronic acid, reparative
techniques (eg, abrasion, microfracturing, drilling), and reconstructive
techniques (eg, autologous chondrocyte implantation, matrix-induced
chondrocyte implantation, and osteoarticular transfer), diagnosis of
early changes has become increasingly important. Follow-up imaging
and monitoring of the therapeutic effects of any of those treatment
options also demand for advanced reliable imaging techniques.3
Magnetic resonance imaging techniques for assessing the ar-
ticular cartilage can be distinguished into techniques for evaluation of
either its morphology or its composition. Techniques for morpho-
logic assessment include all standard 2-dimensional (2D) magnetic
resonance (MR) sequences such as spin-echo (SE) and fast SE (FSE)
sequences as well all 3-dimensional (3D) sequences (3D FSE, 3D
spoiled gradient echo, 3D dual echo steady state, 3D balanced steady-
state free precession, 3D driven-equilibrium fourier transformation,
and 3D FSE sampling perfection with application optimized contrast
using different flip angle evolutions).1,3 Strengths and drawbacks of
each different morphologic imaging sequence vary and were dis-
cussed in detail in a recent publication by Crema et al.3 In this article,
various techniques for compositional articular cartilage assessment
are presented, additionally including T2 mapping, delayed gadolinium
enhanced magnetic resonance imaging of cartilage (dGEMRIC), T1Q
mapping, sodium imaging, and diffusion-weighted imaging.1,3Y5
However, there is another technique for evaluating the articular car-
tilage, which has recently gained much interest, namely, T2* map
ping. A sharp increase in publications was seen lately,2,6Y15 with first
clinical trials already showing the application of this technique in dis-
eased cartilage and in patients. To the best of our knowledge, there is
currently no comprehensive overview of the current status of research
in T2* mapping. Thus, the purposes of this article were to provide a
descriptive review the current literature, to briefly discuss the technique
itself, and to provide an outlook on future research questions and pos-
sible clinical applications. A search in the MEDLINE and EMBASE
databases as well as the Cochrane Library was performed using stan-
dardized key words (T2*, T2star, T2 mapping, mapping and cartilage,
and MR imaging and cartilage) to identify all relevant articles.
TECHNIQUE
Similar to T2 mapping, T2* mapping uses the characteristics of
transverse relaxation of the articular cartilage. It is known from several
studies that the transverse relaxation of cartilage contains different
components.8,16Y20 In agreement with several previous reports,17,18,20 a
recent study by Reiter et al16 described 3 components, with the first
component showing T2 times of approximately 2 milliseconds and the
second and third components showing T2 times of approximately
25 milliseconds and 150 milliseconds, respectively. The authors
assigned the components, with the T2 increasing, to relatively immo-
bile collagen-bound water, to water bound to the articular cartilage’s
proteoglycans, and to water loosely associated with proteoglycans.16
Another in vitro study by Lattanzio et al21 observed 4 different com-
ponents with T2 times of approximately 0.02, 1, 4, and larger than
20 milliseconds. The authors assigned those 4 components to collagen,
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mobile macromolecules (ie, proteoglycans), collagen fibrillar water
(ie, water trapped within collagen fibrils), and bulk water. Although
the exact number and assignments of the different relaxation com-
ponents is still unclear and although there are some interpretational
differences among previous studies, they all agree on the existence
of a long transverse relaxation component in the articular cartilage
of approximately 20 to 30 milliseconds associated with bulk water
and a short-living component with a T2 of 2 to 4 milliseconds,
which is commonly assumed to be associated with relative immobile
collagen-bound water.16,18Y21
Local T2 values can be determined through T2 mapping using
multiecho (ME) SE methods.3 As a more time-efficient alternative,
T2* mapping can be performed using ME gradient recalled echo
(GRE) techniques. Studies using 2D or 3D ME-GRE techniques
typically used a range of echo times (TEs) between 4 and 70
milliseconds,6,7,12,13,15,22Y24 which enabled to measure T2* times of
the longer components (920 milliseconds). However, because shorter
TEs are usually not possible with clinical imaging sequences, the
very short-living components cannot be detected with these techniques.
Yet, the short component with T2 of approximately 2 to 4
milliseconds would be of particular interest in the course of the
aforementioned osteoarthritis development, which includes deterio-
ration of the collagen network in the early phase. More recently, ul-
trashort TE (UTE) imaging is being used for T2* mapping of the
articular cartilage, which allows to decrease TE to 0.5 milliseconds or
even 8 Ks and to detect the short components.8,10,25Y27 Very recently,
Du et al10 presented a new technique where a dual adiabatic inversion
recovery UTE sequence was used to selectively visualize the short-
living T2 components of the articular cartilage. It uses adiabatic
preparation pulses, which invert and null the magnetization of the
longer T2 components of the articular cartilage and of marrow fat of
the adjacent bone.28 In general, 2D and 3D versions of UTE imaging
exist, readouts are performed on radial or spiral trajectories, and the
acquisitions with different TEs are performed either after a single or
after separate excitations.
Geometric parameters were different among recent studies
depending on whether articular cartilage specimens were scanned in
vitro12,27 or whether patients underwent imaging.7 In these studies,
in-plane resolution ranged from 0.12 to 0.39 mm for in vitro imaging
and 0.42 to 0.6 mm for in vivo imaging. The choice of radio-
frequency coils depended on the subject matter and limits compara-
bility of studies because coil-related differences in the signal-to-noise
ratio of the raw images influence the fitting accuracy of the relaxa-
tion time calculation.14,29 Most current studies were performed using
a 3.0-T scanner from 1 of the 3 main vendors (Siemens Healthcare,
Erlangen, Germany; GE Healthcare, Waukesha, WI; Philips Healthcare,
Best, The Netherlands). Only 1 group has published data from a
1.5-T scanner,30 and so far, only 1 group from Vienna has published
data from a 7.0-T scanner (Siemens).22,31 Acquisition time was rel-
atively short in most studies (G5 minutes) and related to the total
scan volume. Postprocessing included fitting of the relaxation decay
for which algorithms typically written in MATLAB (The Mathworks
Inc, Natick, MA)11,16,30 or interface definition language (IDL; Exelis
Visual Information Solutions, Boulder, CO),31 dedicated software
(MRIMapper software; Beth Israel Deaconess andMIT 2006),26 or inline
processing packages (SyngoMapIt; Siemens)7,12 were used, as well as
region-of-interest (ROI)Ybased measurements of T2* times on T2*
maps. For the latter, manual ROI placement was used in all studies, again
using various software packages.7,11,12,14,32 In addition, fractions of the
different T2* components were determined in some studies.8,16Y20,27
POTENTIAL OF T2* MAPPING
An ex vivo study by Qian et al27 evaluated the different
components of the articular cartilage using UTE-based T2* mapping
with the shortest TE approaching 0.5 milliseconds and the longest TE
being 40 milliseconds with 11 steps in between. Four different types
of T2* decay models with monoexponential, biexponential, triex-
ponential, and nonexponential characteristics were used for the
identification of the different transverse relaxation components.
Short T2* components with a range of 1 to 6 milliseconds were
found and assigned to trapped water. Components with long T2*
times of approximately 22 milliseconds were also detected and
assigned to free (bulk) water molecules. In addition, the tri-
exponential decay model showed a very short T2* component of less
than 2 milliseconds, which was considered to represent contribution
from fragmented (mobile) proteoglycans.27 In their study, Qian et al27
also imaged enzymatic degraded cartilage specimen and found that,
in the diseased cartilage, the short T2* times (1Y6 milliseconds) were
shortened. There was no effect, however, on the long T2* times (920
milliseconds). Different findings were reported in a very recent study
by Pauli et al,8 who compared T2* mapping with biexponential
analysis and T2 mapping with monoexponential analysis of human
cadaveric patella cartilage with results from histopathology and op-
tical microscopy. In this study, osteoarthritis did not significantly
affect the T2* value of the short-living component, but it was rather
correlated with an increase of its fraction. Furthermore, a significant
reduction of the longer T2* value was observed but not of T2.8
Bittersohl et al14 performed 2 studies where T2* mapping of hip
articular cartilage was applied to 21 femoral head specimens col-
lected from patients with osteoarthritis who underwent total hip
arthroplasty12 and in 29 patients with femoroacetabular impinge-
ment. The authors were able to demonstrate that, with increasing
severity of osteoarthritis (as assessed using the modified Outerbridge
classification), T2* times in diseased portions of articular cartilage
decreased.12,14 An important observation in these studies was that the
most pronounced drop of T2* was seen in the early phase of osteo-
arthritis, namely, between the Outerbridge grade 0 and grade 1. This
is very advantageous for all future clinical applications because it
indicates the potential capability of T2* mapping for detection and
monitoring of early osteoarthritis. However, Bittersohl et al9 did not
perform an analysis of the different T2* components and fractions. A
study by Marik et al13 in 10 patients with osteochondral defects of the
talus and 9 healthy control participants showed contradictory results
with increasing T2* values in the diseased cartilage. However, this
study was limited by the fact that the cartilage at the talus is very thin
and the image resolution was relatively low (0.4 mm  0.4 mm) at a
slice thickness of 3 mm. As a result, the reported mean (SD) of the
obtained T2* values was fairly high at the overall small T2* differ-
ences between patients with moderate cartilage disease and healthy
control participants (11.8 [2.7] milliseconds vs 16.1 [3.2] millisec-
onds, respectively).13
Overall, T2* mapping has the potential to quantitatively reflect
loss of collagen fiber integrity and changes in bound water, which are
the typical early findings in the development of osteoarthritis.6,22,27
REPRODUCIBILITY
Similar to every new imaging technique, T2* mapping has to
prove its reproducibility as well as interobserver and intraobserver
reliabilities. Whereas evidence in the literature for the other compo-
sitional imaging techniques is rather good,1 there are only a few
studies presenting reproducibility data of T2* mapping.11,25,26
Williams et al25 imaged the knees of 11 healthy participants on 3
consecutive days always during the same hours of the day. The
authors observed a precision error of 8% that corresponds to a mean
(SD) T2* time error of 1.2 (1.0) milliseconds when they measured
the overall T2* times of the femoral and tibial articular cartilage
within the central weight-bearing zone of the medial femorotibial
compartment. Newbould et al11 performed a similar study and
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evaluated the test and retest variability by imaging the knees of 18
healthy participants twice a day during a single visit. The authors
reported a lower error with a 2.0% within-subject coefficient of
variation across the entire knee cartilage. However, detailed data
showed that the coefficient of variation was much greater (up to
7.7%) when only portions of the knee cartilage were analyzed. It
needs to be noted that neither study looked at the different T2*
components but rather focused on the overall T2* time of cartilage.
One of the conclusions that might be drawn from these 2 studies is
that the thinner the cartilage, the greater usually the observed vari-
ability.11,25 This might be related to operator-dependent differences
in the segmentation of small structures and could be improved in the
future using automated segmentation software.
In the study by Williams et al,25 the authors evaluated the
intraobserver variability. Therefore, 1 reader repeated all ROI-based
measurements after 3 months. Intraclass correlation coefficients
were calculated and ranged between 0.80 and 0.98, which corre-
sponds to an excellent intraobserver agreement using the interpreta-
tion of Landis and Koch.33 This interpretation was also supported by
the fact that no significant differences could be detected between the
first and second ROI-based measurements by Williams et al.25
Another study by Bittersohl et al14 also reported intraobserver data.
In this study, where 21 femoral head specimens were imaged, 1 reader
performed repeated measurements with a 4-week delay in a small
proportion of the specimens (n = 10). The intraclass correlation (ICC)
was found to be 0.949.
Robust data for the interobserver agreement of T2* measure-
ments were published by Welsch et al.22 In this study, 3 authors with
very different levels of experience (a senior musculoskeletal radiol-
ogist with 25 years’ experience, an orthopedic surgeon with 10 years’
experience, and a young radiologist with 2 years’ experience) per-
formed ROI-based segmentations on T2* maps. As usual in such a
study setting, ICCs were calculated. They turned out to be, on aver-
age, 0.903 for T2* mapping at 3.0 T. The study by Welsch et al22 is,
to the best of our knowledge, so far the only study that, in addition,
reported reproducibility data for T2* mapping at 7.0 T. Interobserver
variability at 7.0 T was slightly higher with ICCs, on average, being
0.875. This somewhat lower interobserver agreement at 7.0 T was
most likely related to the enhanced susceptibility artifacts near the
cartilage-bone interface at 7.0 T, which may obscure the true cartilage
FIGURE 1. A to D, Magnetic resonance images of the right knee of a 37-year-old male healthy volunteer acquired at 3.0 T. A,
Standard transaxial intermediate-weighted FSE MR image (repetition time [TR]/TE, 2640/41 milliseconds; turbo factor, 7) shows
normalmorphology of the retropatellar cartilagewithout any superficial lesions. B, Corresponding single-echo (TE, 4.4milliseconds)
MR image from amultiecho 2D fast low-angle shot (FLASH) GREMR sequence (TR, 620milliseconds; TEs, 4.4, 11.9, 19.4, 27.0, 34.5
milliseconds; in-plane resolution, 0.4 mm). C, Corresponding T2* map calculated with monoexponential fitting illustrates how
ROI-based measurements of the T2* times of the lateral aspect of the patellar cartilage are typically performed. Please note the scale
for the color-encoding of the T2*map on the left imagemargin. D,Magnified overlay image shows depthwise distribution of normal
T2* times.
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borders and have possibly hampered manual ROI placement by
the observers. In general, interobserver agreement was better for the
superficial portions of articular cartilage, most likely because of the
better outline of the cartilage surface with respect to the surrounding
joint fluid.
ZONAL DISTRIBUTION
Corresponding to previous descriptions of a distinct zonal dis-
tribution of T2 across the whole articular cartilage substance,34,35 T2*
also exhibits a clear zonal distribution with typically very low T2*
times in the area of the calcified zone near the bone-cartilage inter-
face and higher T2* times at the cartilage surface (Fig. 1).10 Williams
et al25 used a UTE sequence with a minimal TE of 0.5 milliseconds
and demonstrated an almost-linear increase in monoexponentially
fitted T2* from the deep to the superficial portions of articular carti-
lage (Fig. 3 in the study of Williams et al25). The results of the
statistical analysis of this depthwise variation of T2* showed that the
lowest T2* occurring next to the subchondral bone was significantly
different from T2* times toward the articular surface (P G 0.001). Zonal
variation is seen for all field strengths used, that is, 3.0 and 7.0 T.25,26
As expected, T2* times at 7.0 Twere somewhat lower compared with
3.0 T. Mean (SD) T2* values for the patellar cartilage were 27.6 (4.3)
milliseconds at 3.0 T and 18.3 (4.9) milliseconds at 7.0 T, respectively.
The zonal behavior was generally confirmed by the study of
Pauli et al,8 but different T2* values were obtained after bi-
exponential fitting. They also showed an increase of the fraction of
the short-T2* component from the superficial to the deep zone, an
observation that may explain the stronger decrease of T2* reported in
the study of Williams et al.25
TECHNICAL CONSIDERATIONS AND LIMITATIONS
A major advantage of T2* mapping versus T2 mapping is the
ability of the used UTE techniques to detect signal with much more
rapid transverse relaxation, down to the order of 1 millisecond or
even lower (Fig. 2). Considering the zonal distribution, this enables
to gain detailed information from cartilage areas even near the
subchondral bone, the so-called zone of calcified cartilage, as very
recently shown by Du et al,8,10,26 who reported T2* values from 1.0
to 3.3 milliseconds for the ZCC. In contrast to T2, T2* also reflects
signal decay associated with local field gradients. T2* alterations due
to macroscopic field gradients related to tissue interfaces and im-
perfect shimming must be considered as artifacts (Fig. 3). As men-
tioned by Mamisch et al,7 this could be a particular issue in the daily
clinical setting where patients with metallic implants are imaged or
when metallic particles are present as a result of a prior surgery.7
However, T2* changes due to microscopic field gradients reflecting
structural properties of the tissue can contain valuable information
that is not present in T2 data. Note that, depending on the field dis-
tribution across the image voxel, the observed signal decay is usually
not purely exponential, which can degrade the results of the fitting
procedure. To solve this problem, more advanced fitting would be
required, incorporating appropriate modeling of the signal evolution.
Another important factor and limitation affecting measure-
ments of transverse relaxation is the magic angle effect, which has
been described in numerous publications.27,30,36Y40 Shiomi et al30
specifically investigated T2* mapping of the articular cartilage and
demonstrated statistically significant changes in T2* depending on
the angulation of a joint with respect to the main magnet field.
However, Pauli et al8 found that T2* values are less affected by ori-
entation than T2 values are and that the fractions of the components
do not change significantly. Generally, it should be taken into account
that the magic angle effect may severely influence the comparability
of longitudinal studies when identical subject positioning is not al-
ways guaranteed over time.
Specific technical challenges are posed by the UTE tech-
niques, targeting extremely short TEs. The initial gradient ramping
used during acquisition makes the sequences particularly susceptible
to both off-resonanceY and eddy current-related artifacts, thus re-
quiring careful implementation and setup.28
FURTHER RESEARCH AND POTENTIAL
CLINICAL APPLICATIONS
Currently, only few studies that describe the first clinical ap-
plications of T2* mapping in human articular cartilage exist.
Bittersohl et al41 determined the normative T2* values of the articular
cartilage of the glenohumeral joint in 40 healthy participants using
a 3D ME data image combination sequence with 6 echoes with a
minimum TE of 6.9 milliseconds. The same authors evaluated,
as mentioned previously, T2* times of hip cartilage in 29 patients
with femoroacetabular impingement using a similar technique.14
Buchbender et al15 used T2* mapping, along with native T1
mapping, dGEMRIC, and $R1 imaging to assess articular cartilage
changes of the metacarpophalangeal joint in 16 patients with rheu-
matoid arthritis compared with 13 healthy control participants. The
previously mentioned study by Mamisch et al7 performed T2*
mapping in patients who underwent a microfracturing procedure in
the weight-bearing areas of the femoral knee cartilage. Although an
ME-GRE sequence that had a minimum TE of only 5.7 milliseconds
was used, the distinct zonal (depthwise) distribution of T2* could be
demonstrated in both a healthy control group and the patients who all
had microfracturing. Means (SDs) of T2* times in the fibro-
cartilaginous repair tissue were between 21.0 (4.8) milliseconds
(deep zones) and 27.7 (3.4) milliseconds (superficial zones). To the
best of our knowledge, the study by Mamisch et al7 is the first to
describe T2* mapping in postoperative patients.
Future research should focus on standardization of pulse se-
quences, imaging parameters and protocols, as well as postprocessing
techniques including the different (multiexponential) exponential
fittings. Appropriate fitting models have a tremendous impact on the
detection of the exact number of transverse relaxation components
and their assignments to pathological changes in the biochemical
FIGURE 2. Magnified T2* map of the retropatellar cartilage of
the right knee in a 45-year-old female patient, which was
calculated from a multiecho 2D FLASH GRE MR sequence
(3.0 T; TR, 625 milliseconds; TEs, 4.4, 11.9, 19.4, 27.0, 34.5
milliseconds; in-plane resolution, 0.4 mm). Full thickness of the
retropatellar cartilage was preserved without signs of focal loss;
however, in the central portion, areas with increased
T2* values (ROI position 1) are seenwithin the cartilage with an
otherwise normal zonal behavior (ROI position 2).
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composition of the articular cartilage. Similarly, the selection of TE
times and the signal-to-noise ratio of the acquisition significantly
influences the ability of T2* mapping to detect early changes in the
tissue. The influence of magic angle effects requires further investi-
gation, as does the influence of motion in between the single-echo
acquisitions. Misregistration is likely to have a significant effect on
T2* reliability because it has been seen in recent dGEMRIC studies
in a similar way.23,42,43 Finally, selection of ROIs would benefit from
more user-independent, automated tools. Ultimate acceptance of T2*
mapping as a clinical method might be reached by future studies by
tracking biochemical or ultrastructural changes of the articular car-
tilage in early osteoarthritis. Currently, however, there is no sufficient
evidence to recommend this technique for the clinical routine. It will
be the task of future clinical studies to determine which one of the
various compositional imaging methods (eg, T2, T2*, dGEMRIC,
T1Q mapping, sodium imaging, and diffusion-weighted imaging) is
the best predictor for earliest osteoarthritis and should therefore be
added to clinical imaging protocols. Our hypothesis, however, is that
a combination of 2 or more methods will finally be needed because
they focus on different aspects/biochemical structures of the cartilage
and provide complementary information.
SUMMARY
T2* is a relatively new quantitative biomarker for the articular
cartilage. T2* maps are produced from MR imaging data obtained
with ME-GRE and UTE sequences using exponential fitting
methods. Local T2* values are determined using manual ROI-based
measurements. The results of preliminary studies show a good test-
retest as well as interreader and intrareader reliabilities. Unfortu-
nately, only a few clinical studies are currently available, which
severely limits the data on hand in the literature and leaves many
research questions unanswered. However, T2* mapping has a great
potential for noninvasive compositional cartilage assessment with
several inherent advantages over the widely used quantitative car-
tilage imaging techniques such as T2 mapping. Currently, T2*
mapping needs to be considered as a very interesting research method
FIGURE 3. Set of MR images of the right knee of a 25-year-old female healthy volunteer to simulate inappropriate shimming. A
multiecho 2D FLASH GRE MR sequence (3.0 T; TR, 364 milliseconds; TEs, 4.4, 11.9, 19.4, 27.0, 34.5 milliseconds; in-plane
resolution, 0.4 mm) was used. Left, Gray scale images acquired at a TE of 19.4 milliseconds. Right, The corresponding T2* maps are
shown. Thewindow-and-level setting of the gray scale images as well as the color coding of T2*maps were kept identical. The upper
and lower images only differ in the field homogeneity, which was automatically optimized by the scanner (upper images) and
voluntarily mis-set along the Z dimension (lower images) by the operator by applying a linear magnetic field gradient of 200 KT/m.
Free-hand ROIs were drawn on the anatomic images and copied to an identical location on all 4 images. Mean (SD) T2* time was
22.3 (5.5) milliseconds (upper-right image) and 6.6 (1.7) milliseconds (lower-right image), illustrating a false T2* relaxation time
calculation in case of inappropriate shimming.
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with high potential and future clinical studies with histopathological
correlation are strongly recommended.
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